Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationStem CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanCombined Modality TherapyLymphomaGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinRemission InductionLymphoma, Mantle-CellSalvage TherapyDisease-Free SurvivalHematologic NeoplasmsRecurrenceMyeloablative AgonistsHodgkin DiseaseCyclophosphamideBone Marrow TransplantationLymphoma, B-CellEtoposideHematopoietic Stem CellsCytarabineSurvival RateHematopoietic Stem Cell MobilizationLymphoma, FollicularLymphoma, Large B-Cell, DiffuseSurvival AnalysisVincristineBusulfanCarmustineRetrospective StudiesWhole-Body IrradiationTransplantation ChimeraBone Marrow PurgingThiotepaPrognosisGraft SurvivalLymphoma, T-Cell, PeripheralAntibodies, Monoclonal, Murine-DerivedDoxorubicinFollow-Up StudiesEmbryonic Stem CellsLymphoma, T-CellAntigens, CD34Boronic AcidsAntineoplastic AgentsTissue DonorsAmyloidosisPyrazinesMesenchymal Stem Cell TransplantationTime FactorsDexamethasoneNeoplasm, ResidualLeukemia, Myeloid, AcuteAdult Stem CellsGraft vs Leukemia EffectAntineoplastic Agents, AlkylatingGranulocyte Colony-Stimulating FactorThalidomidePrednisoneVidarabineHistocompatibility TestingMyelodysplastic SyndromesAutograftsGraft vs Tumor EffectCord Blood Stem Cell TransplantationLeukemiaLiver TransplantationIfosfamideImmunosuppressive AgentsLeukapheresisInduction ChemotherapyPluripotent Stem CellsCell DifferentiationPodophyllotoxinAntibodies, MonoclonalT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaStem Cell NicheCell TransplantationMaintenance ChemotherapyFatal OutcomeMesenchymal Stromal CellsHistocompatibilityLymphocyte TransfusionNeural Stem CellsLeukemia, MyeloidProspective StudiesCytomegalovirus InfectionsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAcute DiseaseInduced Pluripotent Stem CellsSiblings